Unite Genomics Announces New Partnership to Personalize Patient Care
WHY IT MATTERS
Unite Genomics, a Mark Cuban portfolio company, has announced a new partnership that can help personalize and tailor patient care insights based on their medical records and spot potential gaps in care. The company’s direct-to-consumer platform uses artificial intelligence to analyze the medical care patients may have received and alert them to missing tests or treatment options.
The Technology
The technology, enabled by healthcare interoperability requirements on providers, presents a new trend in patient engagement. By offering patients a mechanism to share their medical records and then analyze the treatment data to inform them of potentially missing tests and treatments, Unite’s partners take an active role in care conversations.
How it Works
Patients must agree to allow Unite’s platform to access and unify their medical data from multiple providers. Theo Ahadome, Unite’s chief commercial officer, said that 90% of U.S. patients would be able to find their electronic health records accessible through the company’s platform. Unite can access patient records from over 12,000 health systems, thanks to the 21st Century Cures Act and its mandate that healthcare providers provide patients with access to their records.
Benefits
The platform can import over 1,500 EHR data elements, according to Unite’s website. The primary use case for patients is sharing their unified medical records with a new provider, which is much faster than requesting them from multiple providers who may all be sending medical record data by fax, Ahadome explained.
Supporting Treatment Journeys
The DTP platform analyzes patient medical data and physician notes to provide tailored insights through generative AI that could support their treatment journeys. Ahadome said it’s being used through existing partnerships to analyze care gaps related to rare diseases, such as ALS and muscular dystrophy, and breast and lung cancers.
Conclusion
Unite’s partnership with a new pharma company will integrate the AI-enhanced clinical listening technology directly into their patient-engagement efforts. The company’s platform is designed to remove friction from the treatment journey and may improve patient outcomes.
FAQs
Q: What is Unite’s direct-to-consumer platform?
A: Unite’s direct-to-consumer platform uses artificial intelligence to analyze the medical care patients may have received and alert them to missing tests or treatment options.
Q: How does the platform work?
A: Patients must agree to allow Unite’s platform to access and unify their medical data from multiple providers.
Q: How many EHR data elements can the platform import?
A: The platform can import over 1,500 EHR data elements.
Q: What is the primary use case for patients?
A: The primary use case for patients is sharing their unified medical records with a new provider, which is much faster than requesting them from multiple providers who may all be sending medical record data by fax.
